Sanofi's CEO moves to Boston

Share this article:

Sanofi CEO Chris Viehbacher, who has dual German and Canadian citizenship, is moving to Boston. Bloomberg reports that the pharmaceutical chief will not only be closer to subsidiary Genzyme, which is across the Charles in Cambridge, MA, but will also be closer to Chief Strategy Officer David-Alexandre Gros, Genzyme's leader David Meeker and 12 members of the executive committee who also live in the US.

The move has the potential to offer Viehbacher a tax break, though Sanofi did not answer Bloomberg's questions about what this means in terms of what the CEO will pay in French taxes. The company said Viehbacher's move was for personal reasons.

A new city can be hard (haahd in Massachusetts speak), but Wikipedia's got this helpful dictionary for those looking to brush up on their Boston-isms, or just for a handy guide when subtitles would be much appreciated.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.